BlueDot
Latest round
- Series A
Last raised
- Aug 2019
Total raised
- $7M
Investors
- 3
About BlueDot
BlueDot Inc.Founded in 2013 and headquartered in Toronto, Canada, BlueDot Inc. focuses on infectious disease monitoring and response. The company was co-founded by Fatemeh Niari and Kamran Khan, who also serves as CEO.BlueDot provides advanced infectious disease intelligence solutions designed to enhance public health preparedness and response capabilities. Central to their offerings is an always-on global surveillance system that monitors over 190 infectious diseases and syndromes, enabling clients to be the first to know about high-consequence threats. The company utilizes a risk analysis toolkit and predictive intelligence to analyze global data on disease spread, population vulnerability, and outbreak suitability, allowing organizations to make informed decisions regarding their health security. BlueDot's clientele includes governments, public health organizations, and enterprises in various sectors, such as pharmaceuticals and life sciences, aiming to safeguard populations against outbreaks that could disrupt health, economic stability, and social structures.BlueDot generates revenue through subscription-based models and partnerships with various clients, including governments and global enterprises. Clients typically engage with BlueDot through structured agreements that provide access to its suite of intelligence solutions, including outbreak alerts, risk assessments, and forecasting models. These services are tailored to meet the specific needs of different sectors, including public health and pharmaceuticals, ensuring that infectious disease countermeasures are effectively deployed. The transaction structure is designed to facilitate ongoing engagement with clients, providing continuous monitoring and updates on emerging threats. The company aims to expand its global surveillance capabilities and launch new predictive tools tailored for specific industries by the end of 2023. Additionally, BlueDot is targeting growth in new markets, particularly in Europe and Asia, where it sees significant potential for its intelligence solutions.
Who invested in BlueDot
3 investors across 1 round
See all investors in BlueDot
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 7, 2019
Amount
$7M
Investors
Questions about BlueDot
Who invested in BlueDot?
BlueDot has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BlueDot raised?
BlueDot has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BlueDot last raise money?
BlueDot's most recent round on record is a Series A, in Aug 2019.
What does BlueDot do?
BlueDot is a healthcare it company.
Where is BlueDot headquartered?
BlueDot is headquartered in Toronto, Canada.
Which VCs invest in companies like BlueDot?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at BlueDot's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like BlueDot? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.